Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Duration varies based on individual dosing (typical loading phase 0.250.5mg/day
The SELECT cardiovascular outcomes trial, published in the New England Journal of Medicine (2023), demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in people with established cardiovascular disease and overweight or obesity who did not have diabetes
Trials show very large weight reductions
What is the difference between GLP-1 medications like Liraglutide and Semaglutide
If gastrointestinal symptoms are severe or persistent despite conservative measures, medical review is essential to exclude other pathology and consider alternative management approaches
M., Earle, D., Diamond, L
US$ 23.70
US$ 23.93
US$ 24.04
US$ 25.51
US$ 21.80
US$ 29.32
US$ 24.33
US$ 21.82
